These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 36368311)

  • 1. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future.
    Ohashi T; Nagashima M; Kawai N; Ohmagari N; Tateda K
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1603-1614. PubMed ID: 36368311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures Against Antimicrobial Resistance in Children in Japan: Current Status and Future Prospects.
    Kusama Y; Ishiwada N
    Pediatr Infect Dis J; 2022 Sep; 41(9):e383-e387. PubMed ID: 35763683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.
    Saleem Z; Godman B; Azhar F; Kalungia AC; Fadare J; Opanga S; Markovic-Pekovic V; Hoxha I; Saeed A; Al-Gethamy M; Haseeb A; Salman M; Khan AA; Nadeem MU; Rehman IU; Qamar MU; Amir A; Ikram A; Hassali MA
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):71-93. PubMed ID: 34038294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening the Competitiveness of Japan's Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan's Highly Productive Firm.
    Okuyama R
    Biol Pharm Bull; 2023; 46(5):718-724. PubMed ID: 37121698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).
    Gu Y; Fujitomo Y; Ohmagari N
    Antibiotics (Basel); 2021 Oct; 10(11):. PubMed ID: 34827231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
    Spellberg B; Guidos R; Gilbert D; Bradley J; Boucher HW; Scheld WM; Bartlett JG; Edwards J;
    Clin Infect Dis; 2008 Jan; 46(2):155-64. PubMed ID: 18171244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in food-producing animals: towards implementing a one health based national action plan in Israel.
    Berman TS; Barnett-Itzhaki Z; Berman T; Marom E
    Isr J Health Policy Res; 2023 Apr; 12(1):18. PubMed ID: 37101188
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.